Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Lafutidine

Lafutidine

pharmaceutical raw materials
Lafutidine structure

Lafutidine 

structure
  • CAS No:

    118288-08-7

  • Formula:

    C22H29N3O4S

  • Chemical Name:

    Lafutidine

  • Synonyms:

    Acetamide,2-[(2-furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]-,(+)-;Acetamide,2-[(2-furanylmethyl)sulfinyl]-N-[4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-butenyl]-,(Z)-(+)-;Acetamide,2-[(2-furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-butenyl]-,(+)-;(+)-2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]acetamide;FRG 8813;Laflutidine;(+)-2-(Furfurylsulfinyl)-N-[(Z)-4-[[4-(piperidinomethyl)-2-pyridyl]oxy]-2-butenyl]acetamide;(+)-Lafutidine;Lafutidine;Stogar;Protecadin;Lafukem;143375-16-0;169899-20-1

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Lafutidine is a second generation of H2-receptor antagonist. H2-receptor antagonist can strongly inhibit gastric acid secretion compared with conventional drugs such as antacids. Unlike conventional H2-receptor antagonist, lafutidine inhibits gastric acid secretion during daytime as well as nighttime in clinical studies in humans. Lafutidine also has gastroprotective activity independent of its acid antisecretory efficacy, preventing noxious agent-induced gastric mucosal injury and accelerating

Lafutidine Basic Attributes

431.55

431.55

1312995-182-4

DTXSID0046434

29349990

Characteristics

104

1.252±0.06 g/cm3(Predicted)

92.7-94.9°

704.2±60.0 °C(Predicted)

379.7±32.9 °C

1.599

Safety Information

R36/37/38:Irritating to eyes, respiratory system and skin .

24/25

Xi

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P301+P312, P330, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Lafutidine Use and Manufacturing

Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion

Computed Properties

Molecular Weight:431.6
XLogP3:1.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:11
Exact Mass:431.18787759
Monoisotopic Mass:431.18787759
Topological Polar Surface Area:104
Heavy Atom Count:30
Complexity:569
Undefined Atom Stereocenter Count:1
Undefined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Not yet clear

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Suzhong Pharmaceutical Group Co., Ltd.

    China China
    Active
  • Anhui Biochem Pharmaceutical Co., Ltd.

    China China
    Active
  • China Resources Double-Crane Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Lafutidine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.